Parent A, Wilson R C, Zeitlin S, Efstratiadis A
Department of Genetics and Development, Columbia University, New York, NY 10032.
J Mol Biol. 1989 Oct 5;209(3):379-92. doi: 10.1016/0022-2836(89)90004-1.
We describe the development and application of a system of in vitro-assembled splicing complexes that can be used for the identification of protein splicing factors which become associated with the spliceosome at the end of the assembly process ("late" splicing components). A splicing reaction performed in the presence of polyvinyl alcohol is interrupted after 15 to 20 minutes, before the appearance of splicing intermediates and products in significant amounts. Following low-speed centrifugation, a pellet is obtained containing splicing complexes that can be solubilized with 0.6 M-KCl. These complexes can be rapidly complemented for splicing in the presence of ATP and Mg2+ with protein factors that are present in HeLa cell nuclear extracts or in chromatographic extract fractions. Biochemical features of the complementation reactions, and conditions for reversible uncoupling of the two splicing steps, are described and discussed. These conditions are used to generate fully assembled spliceosomes in which splicing of the pre-mRNA can occur in the presence of ATP and Mg2+, but in the absence of nuclear extract ("autonomous splicing").
我们描述了一种体外组装剪接复合体系统的开发与应用,该系统可用于鉴定在组装过程结束时与剪接体结合的蛋白质剪接因子(“晚期”剪接成分)。在聚乙烯醇存在下进行的剪接反应在15至20分钟后中断,此时尚未大量出现剪接中间体和产物。低速离心后,获得含有剪接复合体的沉淀,该复合体可用0.6M - KCl溶解。这些复合体可在ATP和Mg2+存在下,与HeLa细胞核提取物或色谱提取物组分中的蛋白质因子快速互补进行剪接。描述并讨论了互补反应的生化特性以及两个剪接步骤可逆解偶联的条件。这些条件用于生成完全组装的剪接体,其中前体mRNA的剪接可在ATP和Mg2+存在但无核提取物的情况下发生(“自主剪接”)。